Novel Rapid-Acting Drug Proves Effective in Severe PTSD

(MedPage Today) — The investigational neuroplastogen TSND-201 showed significant efficacy in patients with severe post-traumatic stress disorder (PTSD), according to results from a phase II randomized trial.
Among 65 patients, treatment with…